Related Experiment Videos
Invasive cutaneous melanoma in elderly patients
1Specialized Center for Cancer Research and Education, University of Illinois Medical Center, Chicago.
Archives of Dermatology
|August 1, 1991
Summary
Elderly patients (≥70 years) with cutaneous melanoma often present with thicker tumors and poorer prognostic features compared to younger adults (30-39 years). This age-related disparity contributes to a higher mortality risk in older individuals with melanoma.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Cutaneous melanoma incidence and outcomes vary significantly across age groups.
- Understanding age-related differences in melanoma presentation and prognosis is crucial for tailored treatment strategies.
Purpose of the Study:
- To compare clinical and pathological variables between older (≥70 years) and younger (30-39 years) patients with primary invasive cutaneous melanoma.
- To identify prognostic factors influencing survival in different age cohorts.
Main Methods:
- Retrospective comparison of clinical and pathological data.
- Analysis of melanoma subtype, tumor thickness, invasive level, ulceration, and clinical stage.
- Survival analysis stratified by age group.
Main Results:
- Older patients more frequently had nodular melanoma and acral lentiginous melanoma, while younger patients predominantly had superficial spreading melanoma.
- Mean tumor thickness was significantly greater in older patients (3.95 mm) versus younger patients (2.02 mm).
- Older patients exhibited higher rates of invasive level 5 and microscopic ulceration, indicative of poorer prognostic features.
Conclusions:
- Elderly patients with cutaneous melanoma are more likely to present with adverse prognostic indicators.
- These factors contribute to a higher likelihood of melanoma-related mortality in the elderly compared to younger adults.
- Age is a significant determinant of melanoma behavior and patient outcomes.